Cite

HARVARD Citation

    Zahir, H. et al. (2021). Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein. Journal of clinical pharmacology. pp. 298-306. [Online]. 
  
Back to record